BB BIOTECH AG - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Esperion Therapeutics, Inc. (ESPR)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Esperion Therapeutics, Inc. Common Stock
Symbol: ESPR
Shares outstanding: 199M shares
Disclosed Ownership: 9.94M shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 02:37 PM
Date of event: Dec 31, 2024
Next filing: Mar 10, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	5%	9.94M	0	9.94M	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Target N.V.	5%	9.94M	0	9.94M	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority